Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer-Reference-Cited by-同舟云学术

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

Published:2008-02 Issue:2 Volume:108 Page:317-325
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Thomas Gillian,Ali Shamshad,Hoebers Frank J.P.,Darcy Kathleen M.,Rodgers William H.,Patel Malti,Abulafia Ovardia,Lucci Joseph A.,Begg Adrian C.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference43 articles.

1. Improved treatment for cervical cancer—concurrent chemotherapy and radiotherapy;Thomas;N Engl J Med,1999

2. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix;Grogan;Cancer,1999

3. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix;Pearcey;J Clin Oncol,2002

4. The effect of alterations in hematocrit on tumor sensitivity to X-rays;Hirst;Int J Radiat Oncol Biol Phys,1984

5. Anemia: a problem or an opportunity in radiotherapy;Hirst;Int J Radiat Oncol Biol Phys,1986

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple‐negative breast cancer;Immunology;2024-07-02

2. Prognostic impact of erythropoietin‐stimulating agent use during front‐line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study;International Journal of Gynecology & Obstetrics;2024-04-29

3. Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies;Journal of Thrombosis and Thrombolysis;2024-04-20

4. Repurposing radiosensitising medicines for radiotherapy: an overview;BMJ Oncology;2024-01

5. New Paradigms in the Treatment of Cervical Cancer;Obstetrics & Gynecology;2023-10-12